NFKB1 and colorectal cancer: Yao W and Guan Y emphasized that ginsenoside Rg3 slowed the development of colorectal cancer by inhibiting the nuclear translocation of C/EBP β and its interaction with NF-kB, thereby inhibiting the inflammatory pathway26.